Minmin Zhou

State Key Laboratory Of Emerging Infectious Diseases, Hong Kong Special Administrative Region, Hong Kong
Lika, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Japanese encephalitis virus NS1 and NS4B synergistically target TLR3 signaling to promote viral replication.

Japanese encephalitis virus NS1 and NS4B synergistically target TLR3 signaling to promote viral replication.

Journal: mBio

Published: May 01, 2026

Role of Src family kinases Fyn and Lyn in arenavirus infection.

Role of Src family kinases Fyn and Lyn in arenavirus infection.

Journal: Journal of virology

Published: March 31, 2026

Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Nature communications

Published: December 15, 2025

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Research square

Published: November 28, 2024

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo.

Journal: Nature communications

Published: November 14, 2024

Antiviral Activity of the MEK1/2 Inhibitor Trametinib Against Lymphocytic Choriomeningitis Virus.

Antiviral Activity of the MEK1/2 Inhibitor Trametinib Against Lymphocytic Choriomeningitis Virus.

Journal: Journal of medical virology

Published: October 31, 2024

Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.

Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.

Journal: Acta pharmaceutica Sinica. B

Published: May 22, 2024

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3.

Journal: Nature communications

Published: April 12, 2024

An adenosine analog shows high antiviral potency against coronavirus and arenavirus mainly through an unusual base pairing mode.

An adenosine analog shows high antiviral potency against coronavirus and arenavirus mainly through an unusual base pairing mode.

Journal: Nature communications

Published: February 21, 2024

Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion.

Deletion of the first glycosylation site promotes Lassa virus glycoprotein-mediated membrane fusion.

Journal: Virologica Sinica

Published: January 11, 2023

Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library.

Screening and Identification of Lassa Virus Entry Inhibitors from a Fragment-Based Drug Discovery Library.

Journal: Viruses

Published: October 24, 2022

Developing Next-Generation Protein-Based Vaccines Using High-Affinity Glycan Ligand-Decorated Glyconanoparticles.

Developing Next-Generation Protein-Based Vaccines Using High-Affinity Glycan Ligand-Decorated Glyconanoparticles.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 12, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026